Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Korea University College of Medicine, 148, Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
World J Surg. 2022 Oct;46(10):2517-2525. doi: 10.1007/s00268-022-06660-4. Epub 2022 Jul 25.
Robot-assisted lobectomy has been used to treat non-small cell lung cancer and usually uses 3 or 4 ports and 3 or 4 robotic arms. We recently developed a two-port approach for robotic lobectomy using three robotic arms and performed a propensity score-matched analysis to compare the feasibility of the two-port and three-port techniques.
Data on robotic lobectomy for non-small cell lung cancer were retrospectively reviewed. Patients were matched using propensity score based on age, sex, smoking, diabetes, hypertension, forced expiratory volume per 1 s, neoadjuvant chemotherapy, clinical stage, lobe involved, tumor size, and cell types. Overall, 53 and 89 patients who underwent the two-port and three-port approaches, respectively, were matched (1:1 ratio; caliper distance, 0.2). We analyzed the perioperative outcomes and postoperative pain to evaluate the feasibility and safety.
The matched group included 37 patients each who underwent two-port and three-port robotic lobectomy. The operation time was shorter in the two-port group (P = .01). The number of lymph nodes resected (P = .70), conversion to multiport or thoracotomy (P > .99), morbidity and mortality (P = .31), drain indwelling time (P = .32), and hospital stay (P = .11) were not significantly different between the groups. The postoperative pain was less at 0-3 postoperative days (P < .01) in the two-port group. The total medical cost was not markedly increased after transitioning to the two-port technique.
Two-port approach in robotic lobectomy is a safe and feasible alternative approach for treating non-small cell lung cancer.
机器人辅助肺叶切除术已用于治疗非小细胞肺癌,通常使用 3 或 4 个端口和 3 或 4 个机器臂。我们最近开发了一种使用三个机器臂的两端口机器人肺叶切除术方法,并进行了倾向评分匹配分析,以比较两端口和三端口技术的可行性。
回顾性分析了非小细胞肺癌机器人肺叶切除术的数据。根据年龄、性别、吸烟、糖尿病、高血压、1 秒用力呼气量、新辅助化疗、临床分期、肺叶受累、肿瘤大小和细胞类型等因素,采用倾向评分进行患者匹配。总共匹配了 53 例和 89 例分别接受两端口和三端口方法的患者(1:1 比例;卡尺距离,0.2)。我们分析了围手术期结果和术后疼痛,以评估可行性和安全性。
匹配组中,分别有 37 例患者接受了两端口和三端口机器人肺叶切除术。两端口组的手术时间更短(P = .01)。淋巴结切除数目(P = .70)、转换为多端口或开胸(P > .99)、发病率和死亡率(P = .31)、引流管留置时间(P = .32)和住院时间(P = .11)在两组之间无显著差异。两端口组术后 0-3 天的疼痛较轻(P < .01)。过渡到两端口技术后,总医疗费用并未显著增加。
机器人肺叶切除术的两端口方法是治疗非小细胞肺癌的一种安全可行的替代方法。